|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| Research and development | |||||
| General and administrative | |||||
| Long-lived assets impairment | |||||
| Right of use asset impairment | |||||
| Loss on sale of fixed assets | |||||
| Total operating expenses | |||||
| Other income | |||||
| Interest income | |||||
| Paycheck Protection Program loan forgiveness | |||||
| Rental income | |||||
| Gain from elimination of ARO obligation, net | |||||
| Derivative gain | |||||
| Total other income | |||||
| Net loss | |||||
| Net loss per common share: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average number of common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
